Background and Aims: We have reported that the elevation of B cell activating factors, such as B cell activating factor belonging to the tumor necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) in serum and in bronchoalveolar lavage fluid (BALF) in the patients with autoimmune pulmonary alveolar proteinosis (APAP). From these results, an increase in B-lymphocytes in peripheral blood and BALF is suspected. Therefore, we confirmed the BAFF and APRIL producing cells by immunohistochemically in PAP region and analyzed the ratio of B-lymphocytes in peripheral blood.
Methods: Ten patients with APAP (Male: 7, Female: 3, Age:
5 AE 7 years), 20 healthy controls (Male: 11, Female: 9, Age: 4 AE 2 years) and 10 lung disease controls (Male: 8, Female: 2, Age: 5 AE 8 years) were enrolled in this study. Lung disease controls involved idiopathic pulmonary fibrosis (n = 4), asbestosis, COP, CVD-IP, LC, LIP, sarcoidosis (n = 1, respectively). Immunohistochemical staining was performed by AvidinBiotin Complex method. CD19 and CD20 positive cells were measured by flow cytometryin the peripheral blood and BAL samples. B cell activating factor (BAFF and APRIL) levels in serum and in BALF were measured by ELISA using commercially available kit (R&D systems and eBioscience).
Results: Expression of BAFF and APRIL were confirmed on alveolar macrophages. The CD19 expressed B cells were significantly increased in the patients with APAP compared to healthy control in peripheral blood (P = 0.006). However, there was no differences in CD20-expressing B cells in peripheral blood between APAP and healthy control. And we also confirmed no differences in CD19-and CD20-expressing B cells between APAP and disease controls in BALF. Background and Aims: More than 80% of systemic sclerosis patients have pulmonary involvement, and the interstitial lung disease is the most common form. However, the time sequence of interstitial lung disease (ILD) development in Systemic sclerosis (SSc) is not well defined, and we try to evaluate the chronology of these two manifestations.
Methods: We describe 3 cases of SSc related ILD patients with different presentation of symptoms.
Results: The first case is a 58-year-old male who has SSc with initial presentation as bilateral hands sclerodactyly and positive anti-nuclear antibody (ANA) and anti-Scl70. However, he suffered from progressive dyspnea on exertion about 4 years later, and the image revealed bilateral interstitial infiltration. His pulmonary function deteriorated quickly even under medication treatment and he received lung transplantation 5 years later. The second case is a 62-year-old male initially presented with both bilateral hands sclerodactyly and dyspnea on exertion for 1 month. He is treated with oral prednisolone with stable condition. The third case is a 59-year-old male who had dyspnea on exertion for years. Initially autoantibody screen only showed ANA 1:160 homogeneous. He had received nintedanib for more than 1 year and the sclerodactyly was noted with positive anti-Scl70 later. The patient's pulmonary function seemed stationary during this period.
Conclusion:
We report three SSc patients with different chronology of pulmonary and cutaneous manifestations. The regular physical examination and autoimmune examination are crucial in early detection of different presentation in SSc patients. Methods: A 60-year-old woman who diagnosed multiple myeloma was admitted. There were diffuse proliferation of plasma cells by the bone marrow puncture that she received. And multiple cystic pulmonary tumours found in CT. We analyze the method and result of the diagnosis.
AP506 MULTIPLE CYSTS FORMATION IN PULMONARY LUNG CHAIN DEPOSITION DISEASE (LCDD
Results: CT showed multiple cystic pulmonary tumours with thin wall ranged 5-30 mm in the both lung. There were no abnormality in the heart, kidney and liver. Right upper lobe wedge resection was performed via video-assisted thoracic surgery to establish a definitive diagnosis. Thoracoscopic findings revealed multiple white oval formed tumours in the visceral pleura. Operation time was 126 min, there was not the intraoperative complications. Histological HE staining findings of the surgical specimen revealed amyloid-like acidophilic material, and the immunohistochemical congo red staining revealed monoclonal IgG with a kappa component. According to the above results these tumours had a diagnosis of pulmonary LCDD.
Conclusion: Video-assisted thoracic surgery was effective to diagnose pulmonary LCDD in multiple cysts formation. Background and Aims: Pulmonary alveolar proteinosis (PAP) is a very rare interstitial lung disease. Most of the previously reported cases occurred in male smokers and radiographically exhibited either diffuse or mid-to-basal-predominant involvement of the lung parenchyma. In this thematic poster, we aim to report the clinical, radiographical, and functional findings of a non-smoking young female who developed PAP that predominantly involved her upper lung lobes.
Methods:
The relevant histories, laboratory data, serial thoracic images, histological findings, and serial pulmonary function measurements of the patient were reviewed and will be coherently and graphically presented in this thematic poster. 
